Analyzing Kavar Capital Partners, LLC Q2 2020 vs. Q3 2020 13F Holdings

Kavar Capital Partners, LLC, a registered investment advisor, recently filed their Q3 2020 13F with the Securities and Exchange Commission (SEC). For those not familiar with 13F filings, they are quarterly reports filed by institutional investment managers with at least $100 million in equity assets. The report details their holdings in publicly traded securities, giving us valuable insights into their investment strategy. In this article, we'll take a deep dive into Kavar Capital Partners' Q2 2020 vs. Q3 2020 13F holdings and analyze the changes made.

In Q2 2020, Kavar Capital Partners' top holding was Apple Inc. (AAPL), with 37,488 shares worth approximately $13.7 million. In Q3 2020, they increased their holdings by a whopping 283.8%, owning 143,967 shares worth approximately $16.7 million. This indicates a significant bullish sentiment towards the technology giant. In the same period, they increased their holdings in Schwab Strategic Trust - U.S. Large-Cap ETF (SCHX) by 4.0%, while Schwab Strategic Trust - International Equity ETF (SCHF) saw a modest increase of 0.7%.

Another interesting change was Kavar Capital Partners' increase in holdings of Thermo Fisher Scientific Inc. (TMO) by 0.6%. Despite only a slight increase in shares, the value of their TMO holdings increased by 21.1% from $8.0 million to $9.7 million. This suggests a strong confidence in the life science research tools, analytical instruments, and diagnostic products provider's long-term growth potential.

Kavar Capital Partners made some significant changes in their holdings of Exchange Traded Funds (ETFs) in Q3 2020. Their holdings in Invesco Exchange Traded Fund Trust - S&P 500 Equal Weight ETF (RSP) decreased by 1.8%. Meanwhile, their holdings in Vanguard Index Fds - Small-Cap Value ETF (VBR) increased by 6.3%, and the holdings in Schwab Strategic Trust - US Small-Cap ETF (SCHA) decreased by 4.9%. These changes suggest a shift in the investment manager's ETF strategy, focusing more on small-cap value ETFs.

Kavar Capital Partners also made some significant changes in their holdings of individual stocks. Their holdings in Procter & Gamble Co. (PG) saw a modest increase of 0.2%. However, their holdings in NVIDIA Corporation (NVDA) saw a significant decrease of 5.5%, and holdings in Abbvie Inc. (ABBV) decreased by 1.2%. On the other hand, they increased their holdings in Nike Inc. (NKE) by 2.3%, and Starbucks Corp. (SBUX) by 3.3%, indicating bullish sentiment towards the two consumer goods stocks.

Kavar Capital Partners' Q3 2020 13F filings revealed some surprising changes in their holdings. The investment manager appears to focus more on increasing shares of their top-performing stocks, such as Apple Inc. and Thermo Fisher Scientific Inc., while decreasing holdings in ETFs and individual stocks that underperform. By analyzing 13F filings, investors can gain important insights into institutional investment managers' strategies, which can help guide their own investment decisions.